Antioxidant Therapy against Oxidative Damage of the Inner Ear: Protection and Preconditioning.

Another study involving 242 ovarian cancer patients receiving cyclophosphamide and cisplatin observed a 43% reduction in the incidence of ototoxicity (defined as clinical hearing loss or tinnitus, that required dose reduction or discontinuation of cisplatin treatment); however, the difference with the control group did not reach statistical significance [ 81 ]. 2.6.

also in 111,027 other papers